Skip to main content
Tuberculosis in Tondo, Manila - Ezra Acayan
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.3 million people in 2022, TB is the world’s second deadliest infectious disease after COVID-19.

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic. In 2022, 7.5 million people across 192 countries and areas were diagnosed with TB.
 
Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB. But the harsh reality remains - 10.6 million people fell sick with TB and 410,000 developed multidrug-resistant TB (MDR-TB) in 2022, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2021. The majority go undiagnosed and therefore untreated.

Tuberculosis

Quick facts about tuberculosis

 
Georgia: DR-TB patients find hope in new treatments
Pakistan

Innovative TB trial starts in Sindh province

Press Release 31 Oct 2019
 
Arduous and lengthy treatment of tuberculosis
Tuberculosis

Patients tackle arduous and lengthy tuberculosis treatment in Papua New Guinea

Project Update 30 Oct 2019
 
2018 Union Conference - Johnson & Johnson (J&J) protest
Access to medicines

MSF protests at TB conference against drug corporations keeping lifesaving medicines from people

Press Release 30 Oct 2019
 
Southern Chhatisgarh TB tracing
India

India: treating TB in the jungle

exposure.co 29 Oct 2019
 
Overcoming MDR-TB in Conflict: Lashio Clinic
Myanmar

Displaced couple cured of multidrug-resistant tuberculosis in Shan state

Project Update 17 Oct 2019
 
DMITRY Story: “I have nowhere to go.”
Belarus

TB patients improve treatment adherence with psychological and social support

Project Update 10 Oct 2019
 
OLEG Story: "I’d been through many things in my life, but I’d never experienced anything like it.”
Tuberculosis

TB drug delamanid must be more affordable and made available in more countries

Statement 10 Oct 2019
 
Johnson & Johnson demonstration - bedaquiline
Access to medicines

MSF demands Johnson & Johnson reduce price of lifesaving TB drug

Press Release 10 Oct 2019
 
Advanced HIV in Kinshasa
HIV/AIDS

Burden sharing or burden shifting? How the HIV/TB response is being derailed

Report 7 Oct 2019
fieldresearch.msf.org

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our Tuberculosis-related articles on our dedicated Field Research website.

View site
Osh project, fighting TB